Safety recommendations for administering intravenous prostacyclins in the Hospital

Martha S. Kingman, Kelly Chin

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of nanograms per kilogram per minute and have a narrow therapeutic dosing range for each patient. Sudden increases or decreases in dose can be life threatening. Previous studies revealed errors in the administration of these high-risk infusions, which in some instances led to serious adverse events, including death. The literature was reviewed for safety measures in administration of high-risk intravenous medications and input was obtained from leading experts in pulmonary arterial hypertension to create a set of safety recommendations for infusion of prostacyclins.

Original languageEnglish (US)
Pages (from-to)32-39
Number of pages8
JournalCritical care nurse
Volume33
Issue number5
DOIs
StatePublished - Oct 17 2013

ASJC Scopus subject areas

  • Critical Care

Fingerprint Dive into the research topics of 'Safety recommendations for administering intravenous prostacyclins in the Hospital'. Together they form a unique fingerprint.

Cite this